Hamilton Thorne Ltd. (HTLZF)
| Previous Close | 0.0000 |
| Open | 1.6100 |
| Bid | 1.6000 x 40000 |
| Ask | 1.6200 x 40000 |
| Day's Range | 1.6100 - 1.6100 |
| 52 Week Range | 0.8650 - 1.6250 |
| Volume | |
| Avg. Volume | 6,821 |
| Market Cap | 246.949M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0100 |
| Earnings Date | Nov 14, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Simply Wall St.3 Promising TSX Penny Stocks With Market Caps Under CA$400M
The Canadian market is demonstrating strong momentum as it heads into 2025, supported by a resilient consumer base and rising corporate profits. Amidst this optimistic backdrop, investors are cautioned to consider potential curveballs that could impact their portfolios. While the term "penny stocks" might seem outdated, these investments in smaller or newer companies can still offer significant growth opportunities when backed by solid financial health.
NewsfileHamilton Thorne Reports Revenue for the Quarter and Nine Months Ended September 30, 2024
Revenue of $19.4 million and Adjusted EBITDA of $3.7 million for the quarter Beverly, Massachusetts and Toronto, Ontario--(Newsfile Corp. - November 14, 2024) - Hamilton Thorne Ltd. (TSX: HTL), a leading provider of precision instruments, laboratory equipment, consumables, software, and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported unaudited condensed interim financial results for the quarter and nine months ended September 30, 2024.
